Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa

Krishna P. Reddy, Fatma M. Shebl, Julia H. A. Foote, Guy Harling, Justine A. Scott, Christopher Panella, Clare Flanagan, Emily P. Hyle, Anne M. Neilan, Amir M. Mohareb, Linda-Gail Bekker, Richard J. Lessells, Andrea L. Ciaranello, Robin Wood, Elena Losina, Kenneth A. Freedberg, View ORCID ProfilePooyan Kazemian, Mark J. Siedner
doi: https://doi.org/10.1101/2020.06.29.20140111
Krishna P. Reddy
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
2Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kpreddy@mgh.harvard.edu
Fatma M. Shebl
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia H. A. Foote
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy Harling
4Department of Epidemiology and Harvard Center for Population & Development Studies, Harvard T.H. Chan School of Public Health, Boston, MA, USA
5Africa Health Research Institute, KwaZulu-Natal, South Africa
6Institute for Global Health, University College London, London, UK
7MRC/Wits Rural Public Health & Health Transitions Research Unit (Agincourt), University of Witwatersrand, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justine A. Scott
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Panella
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clare Flanagan
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily P. Hyle
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
8Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
9Harvard University Center for AIDS Research, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne M. Neilan
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
8Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
10Division of General Academic Pediatrics, Massachusetts General Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amir M. Mohareb
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
8Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda-Gail Bekker
11Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard J. Lessells
12KwaZulu-Natal Research Innovation and Sequencing (KRISP), College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea L. Ciaranello
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
8Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
9Harvard University Center for AIDS Research, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robin Wood
11Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Losina
3Harvard Medical School, Boston, MA, USA
13Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
14Orthopedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopedic Surgery, Brigham and Women’s Hospital, Boston, MA, USA
15Policy and Innovation eValuation in Orthopedic Treatments (PIVOT) Center, Department of Orthopedic Surgery, Brigham and Women’s Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth A. Freedberg
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
8Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
16Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA
17Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pooyan Kazemian
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pooyan Kazemian
Mark J. Siedner
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
5Africa Health Research Institute, KwaZulu-Natal, South Africa
8Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Healthcare resource constraints in low and middle-income countries necessitate selection of cost-effective public health interventions to address COVID-19.

Methods We developed a dynamic COVID-19 microsimulation model to evaluate clinical and economic outcomes and cost-effectiveness of epidemic control strategies in KwaZulu-Natal, South Africa. Interventions assessed were Healthcare Testing (HT), where diagnostic testing is performed only for those presenting to healthcare centres; Contact Tracing (CT) in households of cases; Isolation Centres (IC), for cases not requiring hospitalisation; community health worker-led Mass Symptom Screening and diagnostic testing for symptomatic individuals (MS); and Quarantine Centres (QC), for contacts who test negative. Given uncertainties about epidemic dynamics in South Africa, we evaluated two main epidemic scenarios over 360 days, with effective reproduction numbers (Re) of 1·5 and 1·2. We compared HT, HT+CT, HT+CT+IC, HT+CT+IC+MS, HT+CT+IC+QC, and HT+CT+IC+MS+QC, considering strategies with incremental cost-effectiveness ratio (ICER) <US$1,290/year-of-life saved (YLS) to be cost-effective.

Findings With Re 1·5, HT resulted in the most COVID-19 deaths and lowest costs over 360 days. Compared with HT, HT+CT+IC+MS reduced mortality by 76%, increased costs by 16%, and was cost-effective (ICER $350/YLS). HT+CT+IC+MS+QC provided the greatest reduction in mortality, but increased costs by 95% compared with HT+CT+IC+MS and was not cost-effective (ICER $8,000/YLS). With Re 1·2, HT+CT+IC+MS was the least costly strategy, and HT+CT+IC+MS+QC was not cost-effective (ICER $294,320/YLS).

Interpretation In South Africa, a strategy of household contact tracing, isolation, and mass symptom screening would substantially reduce COVID-19 mortality and be cost-effective. Adding quarantine centres for COVID-19 contacts is not cost-effective.

Funding Royal Society, Wellcome Trust, National Institutes of Health

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by a fellowship from the Royal Society and Wellcome Trust [210479/Z/18/Z] and by the National Institutes of Health [K24 AR057827 and T32 AI007433]. The funding sources had no role in the study design, data collection, data analysis, data interpretation, writing of the manuscript, or in the decision to submit the manuscript for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding sources.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Approved by the Partners Human Research Committee under Protocol 2020P000967

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The relevant data are contained within the manuscript and appendix, in published papers, or on publicly available websites.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 01, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa
Krishna P. Reddy, Fatma M. Shebl, Julia H. A. Foote, Guy Harling, Justine A. Scott, Christopher Panella, Clare Flanagan, Emily P. Hyle, Anne M. Neilan, Amir M. Mohareb, Linda-Gail Bekker, Richard J. Lessells, Andrea L. Ciaranello, Robin Wood, Elena Losina, Kenneth A. Freedberg, Pooyan Kazemian, Mark J. Siedner
medRxiv 2020.06.29.20140111; doi: https://doi.org/10.1101/2020.06.29.20140111
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa
Krishna P. Reddy, Fatma M. Shebl, Julia H. A. Foote, Guy Harling, Justine A. Scott, Christopher Panella, Clare Flanagan, Emily P. Hyle, Anne M. Neilan, Amir M. Mohareb, Linda-Gail Bekker, Richard J. Lessells, Andrea L. Ciaranello, Robin Wood, Elena Losina, Kenneth A. Freedberg, Pooyan Kazemian, Mark J. Siedner
medRxiv 2020.06.29.20140111; doi: https://doi.org/10.1101/2020.06.29.20140111

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1101)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9782)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2318)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11656)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (239)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2148)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (220)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2188)
  • Public and Global Health (4673)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)